Psychoactive Substances Act 2016

Last updated

Psychoactive Substances Act 2016
Act of Parliament
Royal Coat of Arms of the United Kingdom (HM Government).svg
Long title An Act to make provision about psychoactive substances; and for connected purposes.
Citation 2016 c. 2
Introduced by Michael Bates and Theresa May. [1]
Territorial extent  England and Wales, Scotland, Northern Ireland. [2]
Dates
Royal assent 28 January 2016
Commencement
  • 26 May 2016. Full enforcement across the United Kingdom
Other legislation
Amends
Repeals/revokes Intoxicating Substances (Supply) Act 1985
History of passage through Parliament
Text of statute as originally enacted
Revised text of statute as amended

The Psychoactive Substances Act 2016 (c. 2) [3] is an Act of the Parliament of the United Kingdom intended to restrict the production, sale and supply of a new class of psychoactive substances often referred to as "legal highs". The bill was given Royal Assent on 28 January 2016, [4] and came into force on 26 May 2016 across the entire United Kingdom.

Contents

Description

The law defines as a "psychoactive substance" anything which "by stimulating or depressing the person’s central nervous system ... affects the person’s mental functioning or emotional state". The law bans all such substances but exempts alcohol, tobacco or nicotine-based products, caffeine, food and drink, medicinal products and any drug that is already regulated under the Misuse of Drugs Act 1971. [5]

The Act:

The act also makes those offences punishable by a fine, or by up to a year in prison (six months in Northern Ireland) if convicted as a summary offence, or up to seven years if convicted under indictment. The Act also defines an offence of possession in a custodial institution (prison, young offenders institution etc.) which has the same penalties as the other offences, except the maximum prison term if convicted under indictment is two years.

The Act also describes a series of aggravating factors which judges or magistrates are obliged to consider in sentencing. These are:

Implementation

In 2015, Home Office minister Mike Penning wrote a letter to representatives of the Roman Catholic Church and the Church of England to try to reassure them that incense would not fall under the jurisdiction of the bill and that churches would not face prosecution for the use of incense during worship. [6]

The Act was due to come into force on 6 April 2016. It was delayed indefinitely due to a lack of clarity as to what the meaning of "psychoactive" is, and what substances are covered by the law. It eventually came into effect on 26 May 2016. [4] The Advisory Council on the Misuse of Drugs also told the Government that alkyl nitrites (poppers) were not covered by the law as they were not considered psychoactive, as they affected the muscles and not the central nervous system. The Government accepted this advice and has stated that poppers are not unlawful under the Act, [7] but nevertheless poppers are not listed as exempted substances in Schedule 1 of the Act; however, this is unnecessary because of how they do not affect the central nervous system. [5]

Criticism

The law has been criticised as an infringement on civil liberties. Barrister Matthew Scott described the act as an attempt to "ban pleasure", saying it could drastically overreach by banning areca nuts, nutmegs, nicotine products, caffeine products, tobacco products, nitrous oxide, poppers, additives used in vaporisers and electronic cigarettes, CBD products, tea, coffee, chocolate, alcoholic beverages, hop pillows, and the sale of toads and salamanders that naturally produce psychoactive substances like bufo alvarius. Scott went further and suggested it may also ban flowers and perfumes as the scents can produce an emotional response. He described it as "bad legislation", compared its drafting with the Dangerous Dogs Act 1991, and described it as incompatible with a conservative philosophy of only banning something when there is clear evidence of harm. [8]

The government's own Advisory Council on the Misuse of Drugs (ACMD) said the law was unworkable as "the psychoactivity of a substance cannot be unequivocally proven", and that it would potentially impede scientific progress by restricting medical research. [9] [10]

Psychopharmacologist and former member of the ACMD, David Nutt, said that the law's apparent ban on poppers (alkyl nitrites) and nitrous oxide was difficult to reconcile with how safe those drugs are in practice, and argued that the (then presumed) ban on poppers was specifically aimed at gay men. [11] The gay rights campaigning group Stonewall said that unless evidence suggested that poppers did any harm, they should be excluded from the ban. [12]

Drugs reformer and founder of the Beckley Foundation, Amanda Feilding claimed the act is bad legislation and a mistake for multiple reasons. She criticised the act for pushing the market underground, meaning users and addicts will have to resort to purchasing from criminals. She also stated the act hampers legitimate research, such as varying drugs effects on illnesses such as depression. Along with these issues she criticised the legislation and the government for trampling on people's personal freedoms and liberties. [13]

Related Research Articles

<span class="mw-page-title-main">Controlled Substances Act</span> United States drug-regulating law

The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and signed into law by President Richard Nixon. The Act also served as the national implementing legislation for the Single Convention on Narcotic Drugs.

<span class="mw-page-title-main">Prohibition of drugs</span> History, effects and enforcement of the prohibition of drugs

The prohibition of drugs through sumptuary legislation or religious law is a common means of attempting to prevent the recreational use of certain intoxicating substances.

<span class="mw-page-title-main">Misuse of Drugs Act 1971</span> United Kingdom legislation

The Misuse of Drugs Act 1971 is an Act of the Parliament of the United Kingdom. It represents action in line with treaty commitments under the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.

Popper is a slang term given broadly to drugs of the chemical class called alkyl nitrites that are inhaled. Most widely sold products include the original isoamyl nitrite or isopentyl nitrite, and isopropyl nitrite. Isobutyl nitrite is also widely used but is banned in the European Union. In some countries, poppers are labeled or packaged as room deodorizers, leather polish, nail polish remover, or videotape head cleaner to evade anti-drug laws.

<span class="mw-page-title-main">Polysubstance use</span> Use of multiple psychoactive substances

Polysubstance use or poly drug use refers to the use of combined psychoactive substances. Polysubstance use may be used for entheogenic, recreational, or off-label indications, with both legal and illegal substances. In many cases one drug is used as a base or primary drug, with additional drugs to leaven or compensate for the side effects, or tolerance, of the primary drug and make the experience more enjoyable with drug synergy effects, or to supplement for primary drug when supply is low.

<span class="mw-page-title-main">Phenazepam</span> Chemical compound

Phenazepam is a benzodiazepine drug, which was developed in the Soviet Union in 1975, and now produced in Russia and some CIS countries.

<span class="mw-page-title-main">Desoxypipradrol</span> Chemical compound

Desoxypipradrol, also known as 2-⁠diphenylmethylpiperidine (2-DPMP), is a drug developed by Ciba in the 1950s which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI).

<span class="mw-page-title-main">Mephedrone</span> Synthetic stimulant drug

Mephedrone, also known as 4-methylmethcathinone, 4-MMC, and 4-methylephedrone, is a synthetic stimulant drug of the amphetamine and cathinone classes. Slang names include drone, M-CAT, White Magic, meow meow and bubble. It is chemically similar to the cathinone compounds found in the khat plant of eastern Africa. It comes in the form of tablets or crystals, which users can swallow, snort or inject, producing effects similar to those of MDMA, amphetamines and cocaine.

<span class="mw-page-title-main">2-Diphenylmethylpyrrolidine</span> Chemical compound

2-Diphenylmethylpyrrolidine (Desoxy-D2PM), also known as 2-benzhydrylpyrrolidine, is a stimulant psychoactive drug. It is the 4-dehydroxylated structural analog of diphenylprolinol (D2PM), and is also similar in structure to desoxypipradrol (2-DPMP), both of which act as norepinephrine-dopamine reuptake inhibitors (NDRIs). Like D2PM and 2-DPMP, Desoxy-D2PM is sold as a designer drug and has been used in the manufacture of legal highs. It has been marketed under the names A3A New Generation, A3A Methano, and Green Powder, and has been reported to cause hallucinations, violent behavior, dilated pupils, tachycardia, and high blood pressure. Literature data suggest that it can produce the same psychotropic effects as other stimulants, but with a longer duration of action.

The powers of the police in Scotland, as with much of Scots law, are based on mixed elements of statute law and common law.

<span class="mw-page-title-main">6-APB</span> Psychoactive drug

6-APB is an empathogenic psychoactive compound of the substituted benzofuran and substituted phenethylamine classes. 6-APB and other compounds are sometimes informally called "Benzofury" in newspaper reports. It is similar in structure to MDA, but differs in that the 3,4-methylenedioxyphenyl ring system has been replaced with a benzofuran ring. 6-APB is also the unsaturated benzofuran derivative of 6-APDB. It may appear as a tan grainy powder. While the drug never became particularly popular, it briefly entered the rave and underground clubbing scene in the UK before its sale and import were banned. It falls under the category of research chemicals, sometimes called "legal highs." Because 6-APB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity.

<span class="mw-page-title-main">Methoxetamine</span> Dissociative drug

Methoxetamine, abbreviated as MXE, is a dissociative hallucinogen that has been sold as a designer drug. It differs from many dissociatives such as ketamine and phencyclidine (PCP) that were developed as pharmaceutical drugs for use as general anesthetics in that it was designed specifically for recreational use. It is a rare example of a drug being so widely controlled without having an existing medical use.

A temporary class drug is a relatively new status for controlled drugs, which has been adopted in some jurisdictions, notably New Zealand and the United Kingdom, to attempt to bring newly synthesised designer drugs under legal control. The controlled drug legislation in these jurisdictions requires drug scheduling decisions to follow an evidence-based process, where the harms of the drug are assessed and reviewed so that an appropriate legal status can be assigned. Since many designer drugs sold in recent years have had little or no published research that could help inform such a decision, they have been widely sold as "legal highs", often for months, before sufficient evidence accumulates to justify placing them on the controlled drug schedules.

<span class="mw-page-title-main">Psychoactive Substances Act 2013</span> Act of Parliament in New Zealand

The Psychoactive Substances Act 2013 is a law in New Zealand. The purpose of the Act is to regulate the availability of psychoactive substances in New Zealand to protect the health of, and minimise harm to, individuals who use psychoactive substances. The law seeks to make manufacturers test and prove their products are low-risk before they can be sold.

Regulation of electronic cigarettes varies across countries and states, ranging from no regulation to banning them entirely. For instance, e-cigarettes were illegal in Japan, which forced the market to use heat-not-burn tobacco products for cigarette alternatives. Others have introduced strict restrictions and some have licensed devices as medicines such as in the UK. However, as of February 2018, there is no e-cigarette device that has been given a medical license that is commercially sold or available by prescription in the UK. As of 2015, around two thirds of major nations have regulated e-cigarettes in some way. Because of the potential relationship with tobacco laws and medical drug policies, e-cigarette legislation is being debated in many countries. The companies that make e-cigarettes have been pushing for laws that support their interests. In 2016 the US Department of Transportation banned the use of e-cigarettes on commercial flights. This regulation applies to all flights to and from the US. In 2018, the Royal College of Physicians asked that a balance is found in regulations over e-cigarettes that ensure product safety while encouraging smokers to use them instead of tobacco, as well as keep an eye on any effects contrary to the control agencies for tobacco.

<span class="mw-page-title-main">Intoxicating Substances (Supply) Act 1985</span> United Kingdom legislation

The Intoxicating Substances (Supply) Act 1985 was a UK Act of Parliament. It made it an offence for people to supply substances that are not controlled by the Misuse of Drugs Act 1971 to people under 18 years of age when it is likely that the substance could be inhaled for the purpose of intoxication. The legislation was drafted in the 1980s due to concern over solvent abuse but was used in the 2010s to prosecute those selling designer drugs that are inhaled. The Act was repealed and replaced by the Psychoactive Substances Act 2016.

Stimulant use disorder is a type of substance use disorder that involves the non-medical use of stimulants. It is defined in the DSM-5 as "the continued use of amphetamine-type substances, cocaine, or other stimulants leading to clinically significant impairment or distress, from mild to severe". These psychoactive drugs, known as stimulants, are the most widely used drugs in the world today. Approximately 200 million Americans have used some type of stimulant in the past year alone.

<span class="mw-page-title-main">Ethylpropyltryptamine</span> Chemical compound

Ethylpropyltryptamine is a rarely encountered psychedelic substance from the tryptamine class, which makes it structurally related to DMT, MET, DET, and DPT.

<span class="mw-page-title-main">Offensive Weapons Act 2019</span> United Kingdom law

The Offensive Weapons Act 2019 is an act of the Parliament of the United Kingdom. The act addresses crimes related to acid attacks ; knife crime prevention orders; the sale of, delivery and possession of knives and other offensive weapons; and introduced further restrictions on firearms. It was introduced to Parliament as a government bill by Sajid Javid and Baroness Williams of Trafford of the Home Office.

References

  1. Psychoactive Substances Act 2016. Parliament. Retrieved 22 May 2017.
  2. According to section 62, amendments and repeals from this act to section 75 the Armed Forces Act 2006 ("power of service policeman to stop and search persons, vehicles etc") may also be extended to the Channel Islands, the Isle of Man and British Overseas Territories under the provisions of the Armed Forces Act 2006.
  3. "Psychoactive Substances Act 2016". www.legislation.gov.uk. Retrieved 25 May 2016.
  4. 1 2 3 4 5 6 7 "Psychoactive Substances Act 2016 - GOV.UK". www.gov.uk. Retrieved 25 May 2016.
  5. 1 2 "Psychoactive Substances Act 2016". www.legislation.gov.uk. Retrieved 25 May 2016.
  6. Travis, Alan (2 October 2015). "Incense in churches safe from new substances bill, say ministers". The Guardian .
  7. Dunt, Ian (30 March 2016). "Psychoactive Substances Act delayed while the Home Office works out what it has banned". politics.co.uk.
  8. Scott, Matthew (2 June 2015). "Theresa May wants to ban pleasure". The Daily Telegraph .
  9. Brooks-Pollock, Tom (3 July 2015). "Theresa May's legal highs ban has been savaged as 'impossible' — by her own advisers". The Independent .
  10. Travis, Alan (5 July 2015). "Theresa May's legal highs ban is unenforceable, say government advisers". The Guardian .
  11. Nutt, David (21 March 2016). "The poppers ban is a veiled attack on pleasure". The Guardian .
  12. "Poppers should not be banned until the evidence is reviewed". Stonewall. 20 January 2016.
  13. Save us from this Act: Why the Psychoactive Substances Act is a bad piece of legislation, says leading expert. Daily Mirror. Published 25 May 2016. Retrieved 12 July 2017.